HK1004469A1 - Apoptosis regulator - Google Patents

Apoptosis regulator

Info

Publication number
HK1004469A1
HK1004469A1 HK98103654A HK98103654A HK1004469A1 HK 1004469 A1 HK1004469 A1 HK 1004469A1 HK 98103654 A HK98103654 A HK 98103654A HK 98103654 A HK98103654 A HK 98103654A HK 1004469 A1 HK1004469 A1 HK 1004469A1
Authority
HK
Hong Kong
Prior art keywords
apoptosis regulator
apoptosis
regulator
Prior art date
Application number
HK98103654A
Other languages
English (en)
Inventor
Satoru Nakai
Koutoku Aihara
Hitomi Mori
Michiaki Tominaga
Masakazu Adachi
Hiroyuki Ichikawa
Seiji Akamatsu
Fumio Saito
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Publication of HK1004469A1 publication Critical patent/HK1004469A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
HK98103654A 1991-07-03 1998-04-29 Apoptosis regulator HK1004469A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP16258791 1991-07-03
JP3346992 1992-02-20
JP4571892 1992-03-03
JP10058592 1992-03-25
PCT/JP1992/000841 WO1993000902A1 (en) 1991-07-03 1992-07-02 Apoptosis regulator

Publications (1)

Publication Number Publication Date
HK1004469A1 true HK1004469A1 (en) 1998-11-27

Family

ID=27459795

Family Applications (1)

Application Number Title Priority Date Filing Date
HK98103654A HK1004469A1 (en) 1991-07-03 1998-04-29 Apoptosis regulator

Country Status (12)

Country Link
US (5) US5672603A (xx)
EP (1) EP0552373B1 (xx)
KR (1) KR100196368B1 (xx)
AU (1) AU648690B2 (xx)
CA (1) CA2090876A1 (xx)
DE (1) DE69230131T2 (xx)
DK (1) DK0552373T3 (xx)
ES (1) ES2138971T3 (xx)
HK (1) HK1004469A1 (xx)
MX (1) MX9203950A (xx)
TW (1) TW229157B (xx)
WO (1) WO1993000902A1 (xx)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2121148A1 (en) * 1992-08-19 1994-03-03 Satoru Nakai Apoptosis regulator
CA2134880A1 (en) * 1993-03-02 1994-09-03 Akira Matsumori Graft rejection inhibitor and il-1 production inhibitor
GB9311132D0 (en) * 1993-05-28 1993-07-14 Eisai London Res Lab Ltd Control of cell death
AU683697B2 (en) * 1993-10-21 1997-11-20 Otsuka Pharmaceutical Co., Ltd. Carbostyril derivative for inhibiting production of interleukin-8
US5504093A (en) * 1994-08-01 1996-04-02 Otsuka Pharmaceutical Co., Ltd. Method for inhibiting nucleoside and nucleobase transport in mammalian cells, and method for inhibition of DNA virus replication
WO1996021449A1 (en) * 1995-01-11 1996-07-18 Otsuka Pharmaceutical Co., Ltd. Pharmaceutical composition of indene derivatives for regulating apoptosis
WO1998046229A1 (fr) * 1995-06-21 1998-10-22 Otsuka Pharmaceutical Co., Ltd. Inhibiteurs de la production d'il-8 et du mcaf
JPH0971532A (ja) * 1995-09-06 1997-03-18 Otsuka Pharmaceut Co Ltd 発癌抑制剤
US5700803A (en) * 1995-12-12 1997-12-23 Otsuka Pharmaceutical Co., Ltd. Method for reducing infarct size in subjects afflicted with ischemic heart disease
WO1998048807A1 (fr) * 1997-04-25 1998-11-05 Otsuka Pharmaceutical Co., Ltd. Inhibiteurs de la synthese de l'hyaluronate
US6008209A (en) * 1997-04-28 1999-12-28 Hoffmann-La Roche Inc. Method of using vitamin D3 analogs with bis C-20 side chains
US6544972B1 (en) 1997-09-25 2003-04-08 Regents Of The University Of Minnesota Methods of limiting apoptosis of cells
US6281191B1 (en) 1997-12-29 2001-08-28 Vladimir I. Slesarev Compositions and methods for treating hepatitis-C
FR2774289B1 (fr) 1998-02-03 2002-05-24 Goemar Lab Sa Medicament pour le traitement des dereglements de l'apoptose
BR9911882A (pt) 1998-07-13 2005-02-15 Univ Texas Processo de tratamento de câncer empregando anticorpos a aminofosfolipìdios
SI1107795T1 (en) 1998-09-04 2003-06-30 The Regents Of The University Of Michigan Thiomolybdate associated with at least one carbohydrate, and its use for preventing or treating diseases characterized by aberrant vascularization, such as cancer, wet type macular degeneration, rheumatoid arthritis
US6277974B1 (en) 1999-12-14 2001-08-21 Cogent Neuroscience, Inc. Compositions and methods for diagnosing and treating conditions, disorders, or diseases involving cell death
US20030044413A1 (en) * 2000-08-15 2003-03-06 Regents Of The University Of Minnesota Methods of limiting apoptosis of cells
US20050107451A1 (en) * 2001-12-20 2005-05-19 Portbury Stuart D. Methods for treating conditions, disorders, or diseases involving cell death
KR101257584B1 (ko) 2002-07-15 2013-04-23 더 보드 오브 리전츠 오브 더 유니버시티 오브 텍사스 시스템 음이온성 인지질 및 아미노인지질에 결합하는 선택된 항체 및 치료하는데 있어서 이의 용도
WO2004043342A2 (en) * 2002-11-07 2004-05-27 Regents Of The University Of Minnesota Methods of treating injuries of the nervous system associated with hemorrhage
US20060204481A1 (en) * 2003-04-02 2006-09-14 Steer Clifford J Methods of promoting cell viability
KR20160106194A (ko) 2004-01-22 2016-09-09 유니버시티 오브 마이애미 국소용 코-엔자임 큐10 제형 및 그의 사용 방법
KR20080012258A (ko) * 2005-02-10 2008-02-11 리전츠 오브 더 유니버스티 오브 미네소타 시각장애를 치료하는 방법
EP2136831B1 (en) 2007-03-02 2012-09-12 The Cleveland Clinic Foundation Anti-angiogenic peptides
US8034905B2 (en) 2007-11-09 2011-10-11 Affitech Research, AS Anti-VEGF antibody compositions and methods

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5430184A (en) * 1977-08-10 1979-03-06 Otsuka Pharmaceut Co Ltd 3,4-dihydrocarbostyril derivative
JPS6038384B2 (ja) * 1978-03-24 1985-08-31 大塚製薬株式会社 チオセミカルバゾン誘導体
JPS5777676A (en) * 1980-10-31 1982-05-15 Otsuka Pharmaceut Co Ltd Carbostyril derivative
JPS5793962A (en) * 1980-12-01 1982-06-11 Otsuka Pharmaceut Co Ltd Carbostyryl derivative
JPS62135423A (ja) * 1985-12-09 1987-06-18 Otsuka Pharmaceut Co Ltd 低酸素症改善剤

Also Published As

Publication number Publication date
EP0552373A4 (en) 1993-09-22
CA2090876A1 (en) 1993-01-04
US5872120A (en) 1999-02-16
TW229157B (xx) 1994-09-01
US5798358A (en) 1998-08-25
US5925640A (en) 1999-07-20
DE69230131D1 (de) 1999-11-18
WO1993000902A1 (en) 1993-01-21
US5672603A (en) 1997-09-30
AU2231792A (en) 1993-02-11
EP0552373B1 (en) 1999-10-13
MX9203950A (es) 1993-05-01
KR100196368B1 (ko) 1999-06-15
AU648690B2 (en) 1994-04-28
DE69230131T2 (de) 2000-03-02
EP0552373A1 (en) 1993-07-28
KR930702002A (ko) 1993-09-08
DK0552373T3 (da) 1999-12-27
ES2138971T3 (es) 2000-02-01
US5916890A (en) 1999-06-29

Similar Documents

Publication Publication Date Title
EP0552373A4 (en) Apoptosis regulator
HU9600083D0 (en) Regulated apoptosis
HU9303393D0 (en) Substituted 3-amino-quinuclidines
ZA927153B (en) Substituted 3-phenylluracils
GB9126311D0 (en) Substituted diphenylsulfides
GB9113899D0 (en) Regulating system
DE69221613D1 (en) Former
ZA924101B (en) Substituted imidazolinylpyrimidines
GB9105123D0 (en) Relaning unit
ZA923936B (en) Substituted 2-arylpyrroles
ZA923739B (en) Substituted 4-hetaryl-pyrazolines
EP0776359A4 (en) REGULATED APOPTOSIS
PL291212A3 (en) Dust-mask
AU213P (en) MOONBEAM Galtonia candicans
AU352P (en) TRIUMPHANT Chamelaucium uncinatum
CA68506S (en) Pom-pom
CA68724S (en) Mobilier-jeu pedagogique
AU206P (en) BUNDERRA Danthonia linkii
AU204P (en) NIRIBI Chamelaucium uncinatum
AU205P (en) TARANNA Danthonia richardsonii
RU1832411C (ru) Paдиoэлektpohhый блok
RU1832410C (ru) Paдиoэлektpohhый блok
ZA92974B (en) Substituted arylsulphonylaminoguanidinotriazines
ZA928677B (en) Substituted biphenlypryridones
HU9500311V0 (en) Case

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)